China Shineway Pharmaceutical Group Limited
CSWYF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $755 | $755 | $702 | $711 |
| - Cash | $6,140 | $858 | $0 | $738 |
| + Debt | $347 | $56 | $0 | $42 |
| Enterprise Value | -$5,038 | -$47 | $702 | $15 |
| Revenue | $3,491 | $287 | $145 | $175 |
| % Growth | 1,115.8% | 98% | -16.9% | – |
| Gross Profit | $2,615 | $216 | $109 | $131 |
| % Margin | 74.9% | 75.3% | 75.1% | 75.2% |
| EBITDA | $1,132 | $88 | $32 | $49 |
| % Margin | 32.4% | 30.7% | 21.9% | 28% |
| Net Income | $754 | $86 | $33 | $36 |
| % Margin | 21.6% | 30% | 22.6% | 20.5% |
| EPS Diluted | 0.996 | 0.114 | 0.043 | 0.047 |
| % Growth | 772% | 163.7% | -8.6% | – |
| Operating Cash Flow | $886 | $78 | $42 | $23 |
| Capital Expenditures | -$130 | -$10 | -$7 | -$4 |
| Free Cash Flow | $756 | $67 | $35 | $20 |